Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile
Maarten Van Hemelen

@maartenvhemelen

Internist. Fellow in intensive care medicine & infectious disease. Views my own.

ID: 38456623

calendar_today07-05-2009 15:54:58

6,6K Tweet

571 Followers

234 Following

Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile Photo

#IDtwitter those of you who have used rifamycins for Pseudomonas treatment, could you point me to the best available evidence for their use, dosage etc? Brad Spellberg Gabe 🦊

Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile Photo

HLH is always scary and challenging. We collaborated with so many people across disciplines and I can think of only very few patients where comparable efforts were made to understand and alter the course of events. Sadly without success...

Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile Photo

Advanced POCUS course today at #IFAD2023, led by Adrian Wong and Segun Olusanya (He/Him) [email protected]. Amazing lectures tying physiology to ultrasound, followed by a chat with faculty. I hope to see more of this in the future!

Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile Photo

Critical diagnosis, can be very impressive! I've seen a case that was misdiagnosed as anaphylaxis, due to severe face and airway edema.

Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile Photo

ID and critical care folks, does anyone know if we have data on the prevalence of meningitis with pneumococcal bacteremia? Ie if we have an intubated septic shock patient with pneumococcal bacteremia, what are the chances they have meningitis? #idxposts #idtwitter

Maarten Van Hemelen (@maartenvhemelen) 's Twitter Profile Photo

Unfortunately this is a predictable result of using antibacterials regularly for a significant part of the general population. There's also no reason to believe Enterobacter ales and gonorrhoea won't follow the same curve. DoxyPEP is fundamental different from ART-P(r)EP.